skip to main content
Show Results with:

Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial

Nallamothu, B. K. et al.

European heart journal. VOL 26; NUMB 15, ; 2005, 1506-1512 -- Elsevier Science B.V., Amsterdam (pages 1506-1512) -- 2005

Online access

Searching Remote Databases, Please Wait